| Amy Schaffarzick, SLP-CCC | |
|
1208 Elk St, Kemmerer, WY 83101-3916 | |
| (307) 877-6984 | |
| (307) 877-9650 |
| Full Name | Amy Schaffarzick |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 1208 Elk St, Kemmerer, Wyoming |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063964526 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SP-859 (Wyoming) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Amy Schaffarzick, SLP-CCC Po Box 570, Mountain View, WY 82939-0570 Ph: (307) 782-6602 | Amy Schaffarzick, SLP-CCC 1208 Elk St, Kemmerer, WY 83101-3916 Ph: (307) 877-6984 |
News Archive
Researchers demonstrate a method of detecting the presence and mutations in the SARS-CoV-2 virus using the smaller and cheaper Oxford Nanopore sequencer, a method they believe could make pandemic surveillance faster and cheaper.
Patients with Medicare or Medicaid, the uninsured, the elderly and the critically ill are the heaviest users of ambulances for transport to the emergency department, making them most vulnerable during periods of ambulance diversion. The results of a study of more than 30,000 patients taken to emergency departments by ambulance were published online Friday in Annals of Emergency Medicine ("At-Risk Populations and the Critically Ill Rely Disproportionately on Ambulance Transport to Emergency Departments").
A clinical study by Dr. Jay Hoffman, PhD, professor and chair of the Department of Health and Exercise Science at the College of New Jersey, has shown Sustamine™ L-Alanyl-L-Glutamine, increases performance in endurance exercise and activity. The study was published on February 3, 2010, in the Journal of the International Society of Sports Nutrition (JISSN), a peer-reviewed journal covering various aspects of sports nutrition, supplementation, exercise metabolism, and/or scientific policies related to sports nutrition.
Bristol-Myers Squibb Company today announced that new data from studies investigating its immunotherapies in adjuvant and advanced melanoma, non-small cell lung cancer (NSCLC) and metastatic renal cell carcinoma (mRCC) will be presented at the 50th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago from May 30-June 3.
› Verified 7 days ago
Natosha Clatterbaugh, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1208 Elk Street, Kemmerer, WY 83101 Phone: 307-877-6984 |